Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
|
2026. Október 01. Malvin napja van
2026. Október 01. Malvin napja van
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
|
